BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21752916)

  • 1. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.
    Leonard S; Wei W; Anderton J; Vockerodt M; Rowe M; Murray PG; Woodman CB
    J Virol; 2011 Sep; 85(18):9568-77. PubMed ID: 21752916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
    Wille CK; Li Y; Rui L; Johannsen EC; Kenney SC
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.
    Mohamed G; Vrzalikova K; Cader FZ; Vockerodt M; Nagy E; Flodr P; Yap LF; Diepstra A; Kluin PM; Rosati S; Murray P
    J Gen Virol; 2014 Sep; 95(Pt 9):1861-1869. PubMed ID: 24893782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J; Hansmann ML; Rajewsky K; Küppers R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.
    Birdwell CE; Queen KJ; Kilgore PC; Rollyson P; Trutschl M; Cvek U; Scott RS
    J Virol; 2014 Oct; 88(19):11442-58. PubMed ID: 25056883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression.
    Guo R; Zhang Y; Teng M; Jiang C; Schineller M; Zhao B; Doench JG; O'Reilly RJ; Cesarman E; Giulino-Roth L; Gewurz BE
    Nat Microbiol; 2020 Aug; 5(8):1051-1063. PubMed ID: 32424339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
    Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
    PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
    Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
    PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
    Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas.
    Bechtel D; Kurth J; Unkel C; Küppers R
    Blood; 2005 Dec; 106(13):4345-50. PubMed ID: 16131568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.
    Anderton JA; Bose S; Vockerodt M; Vrzalikova K; Wei W; Kuo M; Helin K; Christensen J; Rowe M; Murray PG; Woodman CB
    Oncogene; 2011 Apr; 30(17):2037-43. PubMed ID: 21242977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
    Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
    Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
    PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intersection of Epstein-Barr virus with the germinal center.
    Roughan JE; Thorley-Lawson DA
    J Virol; 2009 Apr; 83(8):3968-76. PubMed ID: 19193789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
    Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
    Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
    Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
    J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.